These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2492530)

  • 21. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
    Preissner KT; Müller-Berghaus G
    J Biol Chem; 1987 Sep; 262(25):12247-53. PubMed ID: 2442161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin binding site, conformational change, and activation of antithrombin.
    Evans DL; Marshall CJ; Christey PB; Carrell RW
    Biochemistry; 1992 Dec; 31(50):12629-42. PubMed ID: 1366018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin.
    Church FC; Meade JB; Treanor RE; Whinna HC
    J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical modification of the Ca(2+)-ATPase of rabbit skeletal muscle sarcoplasmic reticulum: identification of sites labeled with aryl isothiocyanates and thiol-directed conformational probes.
    Wawrzynów A; Collins JH
    Biochim Biophys Acta; 1993 Nov; 1203(1):60-70. PubMed ID: 8218393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine residues are critical for the heparin-cofactor activity of antithrombin III.
    Jorgensen AM; Borders CL; Fish WW
    Biochem J; 1985 Oct; 231(1):59-63. PubMed ID: 4062892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
    Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved automated solid-phase microsequencing of peptides using DABITC.
    Salnikow J; Lehmann A; Wittmann-Liebold B
    Anal Biochem; 1981 Nov; 117(2):433-42. PubMed ID: 6798895
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin-III Denver, a reactive site variant.
    Stephens AW; Thalley BS; Hirs CH
    J Biol Chem; 1987 Jan; 262(3):1044-8. PubMed ID: 3805013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
    Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
    J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M; Blackburn MN; Lawler CM; Mann KG
    J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The N-terminal segment of antithrombin acts as a steric gate for the binding of heparin.
    Fitton HL; Skinner R; Dafforn TR; Jin L; Pike RN
    Protein Sci; 1998 Mar; 7(3):782-8. PubMed ID: 9541411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of chemical modification of tryptophan residues on the properties of human antithrombin III.
    Shah N; Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1990 Feb; 57(3):343-52. PubMed ID: 2315891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies against antithrombin III. Identification of their epitopes and effects on antithrombin III activities.
    Knoller S; Savion N
    Eur J Biochem; 1989 Mar; 180(2):319-26. PubMed ID: 2466666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.
    Carlson TH; Babcock T; Atencio AC; Levinson C; Mora HR
    J Biol Chem; 1988 Feb; 263(5):2187-94. PubMed ID: 3339006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.
    Soons H; Tans G; Hemker HC
    Biochem J; 1988 Dec; 256(3):815-20. PubMed ID: 3265623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.